This corroborates with prior investigations demonstrating the importance of PI3K in the oncogenic potential of Kras mutations in pancreatic cancers.38 These cancers also possess activation of ERK1/2 signaling similar to Kras models and human cancers. This evidence concerns the gene MAPK3 and cancer.